Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants

Homologous boosting with the prototype Novavax COVID-19 vaccine induced robust antibody titers for Omicron BA.1, BA.2, and BA.5 Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the consistency of the manufacturing process A durable immunogenicity response was observed following primary vaccination as well […]

thaipr.net

17 ต.ค. 65

Ascend continues broad expansion into new markets, launches HiDura™ MED portfolio

Ascend Performance Materials today announced a new portfolio of medical grade nylon 6,6 resins and engineered materials for the healthcare market under its HiDura™ brand. HiDura™ MED products meet ISO 10993-5 and 10993-10 testing criteria and can be used in a variety of healthcare applications, including: Medical durables: Braces, patient support, furniture, mobility aids and other […]

thaipr.net

12 ต.ค. 65

Pharming submits a Marketing Authorisation Application to the European Medicines Agency for Leniolisib

Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency   This submission follows the grant of accelerated assessment allowing an expedited review for leniolisib from a standard 210 days to 150 days Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that it has […]

thaipr.net

12 ต.ค. 65

Translumina further strengthens senior leadership to drive next phase of growth

Translumina – a global developer and manufacturer of innovative cardiovascular medical devices, implants and access products – appointed Indranil Mukherjee as Group CEO and Armin Kiser as Managing Director and Chief Operating Officer for the company’s Europe operations.  Indranil is a veteran in the healthcare industry. In his most recent role as Managing Director at […]

thaipr.net

11 ต.ค. 65

JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in Patients with Relapsed or Refractory Follicular Lymphoma

JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products Administration (NMPA) of China has approved the supplemental New Drug Application (sNDA) for its anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product relmacabtagene autoleucel injection (hereafter…

thaipr.net

11 ต.ค. 65

On World Mental Health Day, NCCN Announces Free Updated Distress Screening Tool, Available in More Than 70 Languages

The National Comprehensive Cancer Network’s Distress Thermometer helps people with cancer worldwide receive better care by empowering discussion and recommending best practices for managing psychological wellness. The National Comprehensive Cancer Network® (NCCN®) today announced an updated NCCN Distress Thermometer, available in more than 70 languages, to help people around the world identify and address psychosocial stressors that…

thaipr.net

10 ต.ค. 65

Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma, new study presented at UEG Week suggests

Eating a Mediterranean diet, rich in fibre, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunotherapy response rates and progression-free survival in advanced melanoma patients, a new study presented today at UEG Week 2022 has found. Experts anticipate that the diet will play an important role in the success of immunotherapy and trials […]

thaipr.net

10 ต.ค. 65
1 61 62 63 64 65 133